Value of cytogenetic abnormalities in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study of the MYSEC project.
Articolo
Data di Pubblicazione:
2018
Abstract:
This study shows that an abnormal karyotype is present in approximately one third of SMF and confers a more advanced clinical phenotype. Patients with monosomal karyotype have poor survival independently from the MYSEC-PM risk stratification and need to be identified. These findings reinforce the utility of assessing cytogenetics in SMF.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
cytogenetic, polycythemia vera, myelofibrosis, thrombocythemia
Elenco autori:
Mora, B; Giorgino, T; Guglielmelli, P; Rumi, E; Maffioli, M; Rambaldi, A; Caramella, M; Komrokji, R; Gotlib, J; Kiladjian, Jj; Cervantes, F; Devos, T; Palandri, F; De Stefano, V; Ruggeri, M; Silver, Rt; Benevolo, G; Albano, F; Cavalloni, C; Barraco, D; Merli, M; Pietra, D; Casalone, R; Barbui, T; Rotunno, G; Cazzola, M; Vannucchi, Am; Passamonti, F.
Link alla scheda completa:
Pubblicato in: